Using enzyme-linked immunosorbent assay (ELISA) and flow cytometry, Zhang et al. found that the content of PD-L1 and PD-1 in peripheral blood of patients with cancer pain increased, and the ratio of PD-1+ T cells notably enhanced [59]. Here, CD274 is linked to cancer.